The ticker symbol INSP represents Inspire Medical Systems on the New York Stock Exchange, allowing public shareholders to invest in a specialized medical technology company focused on respiratory health. The corporation designs, develops, and commercializes innovative, FDA-approved neurostimulation systems that treat obstructive sleep apnea by providing an alternative to traditional continuous positive airway pressure therapies.